Actively Recruiting

Phase Not Applicable
Age: 18Years +
FEMALE
NCT07142096

WinQ : a Window of Opportunity Study With MitoQ in Breast Cancer

Led by Université Catholique de Louvain · Updated on 2025-08-26

20

Participants Needed

2

Research Sites

52 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of the study is to validate biomarkers in blood and tumor biopsy in patients with Triple Negative Breast Cancer, after a course of MitoQ treatment

CONDITIONS

Official Title

WinQ : a Window of Opportunity Study With MitoQ in Breast Cancer

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Signed Informed Consent Form (ICF)
  • Ability to comply with protocol, in the investigator's judgment
  • Female aged over 18 years (no upper age limit)
  • ECOG performance status of 0 or 1
  • Histologically documented triple negative breast cancer (negative ER, PR, and HER2 status)
  • Histologically confirmed invasive breast carcinoma
  • Agreement to undergo systemic and surgical management after treatment
  • Adequate hematologic and organ function based on lab results within 14 days before treatment
  • Negative beta-HCG if applicable
  • Availability of quality tumor tissue sample confirming triple negative status
  • For women of childbearing potential: agreement to use effective contraception or abstain during treatment and for one month after
  • Negative serum pregnancy test within 14 days before starting treatment for women not postmenopausal or sterilized
Not Eligible

You will not qualify if you...

  • Male gender
  • Prior systemic therapy for current breast cancer
  • Known allergy or hypersensitivity to MitoQ
  • Active viral hepatitis
  • Known HIV infection with detectable viral load
  • Active tuberculosis
  • Severe infections within 4 weeks before treatment
  • Any condition that contraindicates use of the dietary supplement or affects study results
  • Pregnant, lactating, or intending to become pregnant during the study
  • Undergoing fertility preservation procedures

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Cliniques universitaires Saint-Luc

Brussels, Belgium, 1200

Actively Recruiting

2

Cliniques universitaires Saint-Luc

Brussels, Belgium

Not Yet Recruiting

Loading map...

Research Team

P

Pierre Sonveaux, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

BASIC_SCIENCE

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here